Sinocelltech Group Limited
SSE:688520.SS
46.99 (CNY) • At close June 10, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,512.708 | 1,887.349 | 1,023.177 | 134.393 | 0.328 | 2.638 | 2.946 | 5.993 | 98.126 |
| Cost of Revenue
| 102.702 | 107.296 | 33.877 | 7.041 | 0.059 | 1.873 | 0.544 | 2.2 | 22.288 |
| Gross Profit
| 2,410.006 | 1,780.053 | 989.3 | 127.352 | 0.269 | 0.765 | 2.402 | 3.793 | 75.838 |
| Gross Profit Ratio
| 0.959 | 0.943 | 0.967 | 0.948 | 0.819 | 0.29 | 0.815 | 0.633 | 0.773 |
| Reseach & Development Expenses
| 911.193 | 1,151.525 | 886.027 | 732.662 | 610.307 | 516.176 | 434.773 | 189.173 | 120.202 |
| General & Administrative Expenses
| 61.312 | 51.525 | 26.6 | 22.313 | 21.68 | 19.97 | 10.099 | 6.406 | 5.535 |
| Selling & Marketing Expenses
| 380.305 | 436.15 | 264.787 | 120.777 | 16.477 | 0 | 0 | 1.862 | 16.763 |
| SG&A
| 441.617 | 585.114 | 291.386 | 143.09 | 38.157 | 19.97 | 10.099 | 8.268 | 22.298 |
| Other Expenses
| 488.79 | 37.049 | 84.629 | 88.486 | 61.109 | 258.223 | 0.03 | -0.806 | 62.871 |
| Operating Expenses
| 1,841.6 | 1,773.688 | 1,262.043 | 964.238 | 709.573 | 794.369 | 456.908 | 146.737 | 151.45 |
| Operating Income
| 568.406 | 6.366 | -272.743 | -836.886 | -709.304 | -793.604 | -459.558 | -145.068 | -74.383 |
| Operating Income Ratio
| 0.226 | 0.003 | -0.267 | -6.227 | -2,161.425 | -300.799 | -156.011 | -24.207 | -0.758 |
| Total Other Income Expenses Net
| -456.057 | -403.197 | -162.374 | -31.983 | -0.098 | -4.516 | 0.03 | -0.806 | 62.871 |
| Income Before Tax
| 112.349 | -396.831 | -520.053 | -868.869 | -714.058 | -798.12 | -459.528 | -145.874 | -11.512 |
| Income Before Tax Ratio
| 0.045 | -0.21 | -0.508 | -6.465 | -2,175.913 | -302.511 | -156.001 | -24.342 | -0.117 |
| Income Tax Expense
| 0 | 0 | 1.964 | 32.505 | 16.444 | 7.119 | 2.421 | -1.551 | 2.44 |
| Net Income
| 111.951 | -396.018 | -522.017 | -901.374 | -730.502 | -805.239 | -453.258 | -141.28 | -12.143 |
| Net Income Ratio
| 0.045 | -0.21 | -0.51 | -6.707 | -2,226.021 | -305.21 | -153.873 | -23.575 | -0.124 |
| EPS
| 0.24 | -0.89 | -1.2 | -2.07 | -1.68 | -1.85 | -1.19 | -0.37 | -0.032 |
| EPS Diluted
| 0.24 | -0.89 | -1.2 | -2.07 | -1.68 | -1.85 | -1.19 | -0.37 | -0.032 |
| EBITDA
| 387.727 | -164.459 | -369.626 | -782.566 | -655.887 | -748.86 | -419.509 | -111.876 | 9.112 |
| EBITDA Ratio
| 0.154 | -0.087 | -0.361 | -5.823 | -1,998.651 | -283.84 | -142.415 | -18.669 | 0.093 |